Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Bio-Rad Laboratories, Inc. — Predicate Candidate Screening
82 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
81 daysmedian FDA review time
231 days90th percentile
82clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K181661 | QXDx BCR-ABL %IS Kit for use on the QXDx AutoDG ddPCR System | Bio-Rad Laboratories, Inc. | 2019-02-13 | 233 | 1 |
| K171664 | Hemoglobin Variants System on Newborn Hemoglobin System with | Bio-Rad Laboratories, Inc. | 2017-09-13 | 100 | 0 |
| K161687 | D-10 Hemoglobin A1c Program | Bio-Rad Laboratories, Inc. | 2016-10-14 | 119 | 0 |
| K151321 | D-100 HbA1c, D-100 HbA1c Calibrator Pack | Bio-Rad Laboratories, Inc. | 2015-12-09 | 205 | 0 |
| K142448 | VARIANT II TURBO HbA1c Kit - 2.0 | Bio-Rad Laboratories, Inc. | 2015-03-24 | 203 | 0 |
| K140801 | VARIANT II TURBO LINK HEMOGLOBIN A1C PROGRAM/TESTING SYSTEM | Bio-Rad Laboratories, Inc. | 2014-06-25 | 86 | 0 |
| K130053 | BIOPLEX 2200 CELIAC IGA AND IGG KITS ON THE BIOPLEX 2200 SYS | Bio-Rad Laboratories, Inc. | 2013-09-19 | 247 | 0 |
| K130963 | LIQUICHEK PEDIATRIC CONTROL, LEVEL 1; LIQUICHEK PEDIATRIC CO | Bio-Rad Laboratories, Inc. | 2013-05-06 | 28 | 0 |
| K120504 | LIQUICHEK URINE TOXICOLOGY CONTROL, S10 & S10 MINIPAK, LIQUI | Bio-Rad Laboratories, Inc. | 2012-03-27 | 35 | 0 |
| K120572 | BIOPLEX 2200 TORC IGG | Bio-Rad Laboratories, Inc. | 2012-03-26 | 28 | 0 |
| K120439 | BIOPLEX 2200 EBV IGG AND SYPHILIS IGG | Bio-Rad Laboratories, Inc. | 2012-03-14 | 30 | 0 |
| K092355 | MONOLISA ANTI-HAV EIA | Bio-Rad Laboratories, Inc. | 2009-10-29 | 86 | 0 |
| K092353 | MONOLISA ANTI-HAV IGM EIA | Bio-Rad Laboratories, Inc. | 2009-10-29 | 86 | 1 |
| K090699 | VARIANT II TURBO HBA1C KIT KIT-20 AND WASH/DILUENT SOLUTION | Bio-Rad Laboratories, Inc. | 2009-07-27 | 132 | 0 |
| K090737 | HEMOGLOBIN CAPILLARY COLLECTION SYSTEM (HCCS), 1 TEST, HEMOG | Bio-Rad Laboratories, Inc. | 2009-06-03 | 75 | 0 |
| K080008 | BIOPLEX 2200 SYSTEM TORC IGG KIT, CALIBRATOR SET AND CONTROL | Bio-Rad Laboratories, Inc. | 2009-02-23 | 418 | 0 |
| K070452 | VARIANT II HEMOGLOBIN A1C PROGRAM WITH MODELS 270-2101NU | Bio-Rad Laboratories, Inc. | 2007-05-07 | 80 | 1 |
| K062211 | BIOPLEX 2200 EBV IGG PANEL FOR BIOPLEX 2200 MULTI-ANALYTE DE | Bio-Rad Laboratories, Inc. | 2006-12-08 | 129 | 2 |
| K062213 | BIOPLEX 2200 EBV IGM PANEL ON BIOPLEX 2200 MULTI-ANALYTE DET | Bio-Rad Laboratories, Inc. | 2006-12-08 | 129 | 1 |
| K063400 | VARIANT II TURBO HEMOGLOBIN A1C PROGRAM, HEMOGLOBIN TESTING | Bio-Rad Laboratories, Inc. | 2006-12-01 | 22 | 4 |
| K060001 | D-10 HEMOGLOBIN A1C PROGRAM; D-10 DUAL PROGRAM | Bio-Rad Laboratories, Inc. | 2006-01-20 | 17 | 1 |
| K043341 | BIOPLEX 2200 ANA SCREEN WITH MEDICAL DECISION SUPPORT SOFTWA | Bio-Rad Laboratories, Inc. | 2005-10-27 | 328 | 2 |
| K051072 | BIO-RAD VARIANT NBS SICKLE CELL PROGRAM | Bio-Rad Laboratories, Inc. | 2005-05-12 | 16 | 0 |
| K050682 | LIQUICHEK URINE TOXICOLOGY CONTROL (LEVEL C1) | Bio-Rad Laboratories, Inc. | 2005-04-29 | 44 | 0 |
| K043584 | LIQUICHEK BNP CONTROL | Bio-Rad Laboratories, Inc. | 2005-02-08 | 42 | 0 |
| K041658 | BIOPLEX 200 ANA SCREEN ON THE BIOPLEX 2200 MULTI-ANALYTE DET | Bio-Rad Laboratories, Inc. | 2004-12-20 | 185 | 0 |
| K043108 | LIQUICHEK SPECIALTY IMMUNOASSAY CONTROL | Bio-Rad Laboratories, Inc. | 2004-12-07 | 28 | 0 |
| K042446 | QUANTIFY CONTROL AND QUANTIFY PLUS CONTROLS | Bio-Rad Laboratories, Inc. | 2004-11-02 | 54 | 0 |
| K042336 | METER TRAX TRILEVEL, LOW LEVEL, MID LEVEL, HIGH LEVEL TRILEV | Bio-Rad Laboratories, Inc. | 2004-10-14 | 45 | 0 |
| K042335 | ARCHITECT FREE PSA MASTERCHECK, MODEL 6C07-05; ARCHITECT TIT | Bio-Rad Laboratories, Inc. | 2004-09-17 | 18 | 0 |
| K041444 | BIO-RAD D-10 DUAL PROGRAM | Bio-Rad Laboratories, Inc. | 2004-06-09 | 8 | 2 |
| K040822 | LIQUICHEK TORCH PLUS IGM CONTROL | Bio-Rad Laboratories, Inc. | 2004-05-19 | 50 | 1 |
| K040872 | VARIANT II HEMOGLOBIN A1C | Bio-Rad Laboratories, Inc. | 2004-04-15 | 13 | 4 |
| K040277 | LIQUICHEK CARDIAC MARKER CONTROL LT | Bio-Rad Laboratories, Inc. | 2004-03-10 | 34 | 0 |
| K040273 | LYPHOCHEK ASSAYED CHEMISTRY CONTROL | Bio-Rad Laboratories, Inc. | 2004-03-04 | 28 | 2 |
| K033924 | LIQUICHEK URINE TOXICOLOGY CONTROL (SCREEN SERIES) | Bio-Rad Laboratories, Inc. | 2004-02-03 | 47 | 0 |
| K031043 | D-10 HEMOGLOBIN A1C | Bio-Rad Laboratories, Inc. | 2003-08-27 | 148 | 6 |
| K022041 | LYPHOCHEK WHOLE BLOOD CONTROL, MODELS 561, 562, 563 | Bio-Rad Laboratories, Inc. | 2002-07-16 | 22 | 0 |
| K020817 | LIQUICHEK URINE CHEMISTRY CONTROL | Bio-Rad Laboratories, Inc. | 2002-04-12 | 30 | 0 |
| K970126 | ACCESS ESTRADIOL REAGENTS ON THE ACCESS IMMUNOASSAY ANALYZER | Bio-Rad Laboratories, Inc. | 1997-02-25 | 42 | 0 |
| K960850 | ACCESS CHLAMYDIA ASSAY | Bio-Rad Laboratories, Inc. | 1997-02-04 | 340 | 0 |
| K963934 | ACCESS TROPONIN I REAGENTS ON THE ACCESS IMMUNOASSAY ANALYZE | Bio-Rad Laboratories, Inc. | 1996-12-16 | 76 | 0 |
| K954687 | ACCESS RUBELLA IGG | Bio-Rad Laboratories, Inc. | 1996-04-09 | 181 | 0 |
| K960913 | ACCESS FREE T3 ASSAY | Bio-Rad Laboratories, Inc. | 1996-03-29 | 23 | 1 |
| K955769 | ACCESS PROGESTERONE ASSAY | Bio-Rad Laboratories, Inc. | 1996-02-05 | 46 | 2 |
| K955436 | ACCESS VITAMIN B12 ASSAY (MODIFICATION) | Bio-Rad Laboratories, Inc. | 1996-01-24 | 114 | 1 |
| K955435 | ACCESS TOTAL T3 ASSAY (MODIFICATION) | Bio-Rad Laboratories, Inc. | 1996-01-24 | 114 | 1 |
| K951495 | ACCESS TOXO IGG ASSAY ON THE ACCESS IMMUNOASSAY SYSTEM | Bio-Rad Laboratories, Inc. | 1995-12-20 | 264 | 0 |
| K954733 | ACCESS CORTISOL ASSAY (MODIFICATION) | Bio-Rad Laboratories, Inc. | 1995-12-05 | 64 | 1 |
| K954825 | ACCESS HYPERSENSITIVE TSH REAGENTS ON THE ACCESS IMMUNOASSAY | Bio-Rad Laboratories, Inc. | 1995-11-21 | 32 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda